TY - BOOK AU - Fletcher, C. D. M. PY - 2013 DA - 2013// TI - WHO Classification of Tumours of Soft Tissue and Bone PB - IARC Press CY - New York ID - Fletcher2013 ER - TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2018 DA - 2018// TI - Cancer statistics, 2018 JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21442 DO - 10.3322/caac.21442 ID - Siegel2018 ER - TY - JOUR AU - Rouhani, P. PY - 2008 DA - 2008// TI - Cutaneous soft tissue sarcoma incidence patterns in the US: an analysis of 12,114 cases JO - Cancer VL - 113 UR - https://doi.org/10.1002/cncr.23571 DO - 10.1002/cncr.23571 ID - Rouhani2008 ER - TY - JOUR AU - Willeumier, J. J. PY - 2017 DA - 2017// TI - Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model JO - BMJ Open VL - 7 UR - https://doi.org/10.1136/bmjopen-2016-012930 DO - 10.1136/bmjopen-2016-012930 ID - Willeumier2017 ER - TY - JOUR AU - Daigeler, A. PY - 2014 DA - 2014// TI - Long-term outcome after local recurrence of soft tissue sarcoma: a retrospective analysis of factors predictive of survival in 135 patients with locally recurrent soft tissue sarcoma JO - Br J Cancer VL - 110 UR - https://doi.org/10.1038/bjc.2014.21 DO - 10.1038/bjc.2014.21 ID - Daigeler2014 ER - TY - JOUR AU - Kraybill, W. G. PY - 2006 DA - 2006// TI - Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: radiation Therapy Oncology Group Trial 9514 JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.02.5577 DO - 10.1200/JCO.2005.02.5577 ID - Kraybill2006 ER - TY - JOUR AU - Brennan, M. F. PY - 1999 DA - 1999// TI - Staging of soft tissue sarcomas JO - Ann Surg Oncol VL - 6 UR - https://doi.org/10.1007/s10434-999-0008-5 DO - 10.1007/s10434-999-0008-5 ID - Brennan1999 ER - TY - JOUR AU - Cheng, E. Y. PY - 2005 DA - 2005// TI - Surgical management of sarcomas JO - Hematol Oncol Clin North Am VL - 19 UR - https://doi.org/10.1016/j.hoc.2005.03.009 DO - 10.1016/j.hoc.2005.03.009 ID - Cheng2005 ER - TY - JOUR AU - Mehren, M. PY - 2018 DA - 2018// TI - Soft Tissue Sarcoma, Version 22018, NCCN Clinical Practice Guidelines in Oncology JO - J Natl Compr Canc Netw VL - 16 UR - https://doi.org/10.6004/jnccn.2018.0025 DO - 10.6004/jnccn.2018.0025 ID - Mehren2018 ER - TY - JOUR PY - 1997 DA - 1997// TI - Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data JO - Lancet VL - 350 UR - https://doi.org/10.1016/S0140-6736(97)08165-8 DO - 10.1016/S0140-6736(97)08165-8 ID - ref10 ER - TY - JOUR AU - Woll, P. J. PY - 2012 DA - 2012// TI - Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(12)70346-7 DO - 10.1016/S1470-2045(12)70346-7 ID - Woll2012 ER - TY - JOUR AU - Pervaiz, N. PY - 2008 DA - 2008// TI - A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma JO - Cancer VL - 113 UR - https://doi.org/10.1002/cncr.23592 DO - 10.1002/cncr.23592 ID - Pervaiz2008 ER - TY - JOUR AU - Pasquali, S. PY - 2017 DA - 2017// TI - Neoadjuvant treatment: a novel standard? JO - Curr Opin Oncol VL - 29 UR - https://doi.org/10.1097/CCO.0000000000000372 DO - 10.1097/CCO.0000000000000372 ID - Pasquali2017 ER - TY - JOUR AU - Sabolch, A. PY - 2012 DA - 2012// TI - Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity JO - Am J Clin Oncol VL - 35 UR - https://doi.org/10.1097/COC.0b013e318209cd72 DO - 10.1097/COC.0b013e318209cd72 ID - Sabolch2012 ER - TY - JOUR AU - Grimer, R. J. PY - 2006 DA - 2006// TI - Size matters for sarcomas! JO - Ann R Coll Surg Engl VL - 88 UR - https://doi.org/10.1308/003588406X130651 DO - 10.1308/003588406X130651 ID - Grimer2006 ER - TY - JOUR AU - DeLaney, T. F. PY - 2003 DA - 2003// TI - Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas JO - Int J Radiat Oncol Biol Phys VL - 56 UR - https://doi.org/10.1016/S0360-3016(03)00186-X DO - 10.1016/S0360-3016(03)00186-X ID - DeLaney2003 ER - TY - JOUR AU - Loong, H. H. AU - Wong, K. H. AU - Tse, T. PY - 2018 DA - 2018// TI - Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas JO - ESMO Open VL - 3 UR - https://doi.org/10.1136/esmoopen-2017-000293 DO - 10.1136/esmoopen-2017-000293 ID - Loong2018 ER - TY - JOUR AU - Ratan, R. AU - Patel, S. R. PY - 2016 DA - 2016// TI - Chemotherapy for soft tissue sarcoma JO - Cancer VL - 122 UR - https://doi.org/10.1002/cncr.30191 DO - 10.1002/cncr.30191 ID - Ratan2016 ER - TY - JOUR AU - Tanaka, K. PY - 2015 DA - 2015// TI - Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304) JO - Jpn J Clin Oncol VL - 45 ID - Tanaka2015 ER - TY - JOUR AU - Movva, S. PY - 2015 DA - 2015// TI - Patterns of chemotherapy administration in high-risk soft tissue sarcoma and impact on overall survival JO - J Natl Compr Canc Netw VL - 13 UR - https://doi.org/10.6004/jnccn.2015.0165 DO - 10.6004/jnccn.2015.0165 ID - Movva2015 ER - TY - JOUR AU - Gronchi, A. AU - Jones, R. L. PY - 2018 DA - 2018// TI - The value of neoadjuvant chemotherapy in localized high-risk soft-tissue sarcoma of the extremities and trunk JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2018.1392 DO - 10.1001/jamaoncol.2018.1392 ID - Gronchi2018 ER - TY - JOUR AU - Maretty-Kongstad, K. PY - 2017 DA - 2017// TI - A validated prognostic biomarker score for adult patients with nonmetastatic soft tissue sarcomas of the trunk and extremities JO - Translational Oncology VL - 10 UR - https://doi.org/10.1016/j.tranon.2017.09.002 DO - 10.1016/j.tranon.2017.09.002 ID - Maretty-Kongstad2017 ER - TY - JOUR AU - Schenone, A. D. PY - 2014 DA - 2014// TI - Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy JO - Cancer Med VL - 3 UR - https://doi.org/10.1002/cam4.209 DO - 10.1002/cam4.209 ID - Schenone2014 ER - TY - STD TI - Greto D, et al. Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma. Tumori. 2018. p. 300891618765565. ID - ref24 ER -